Loading…
Achieve Life Sciences, Inc. is projected to rise to $8.51 by 2027, a +33% move from its current price of $6.42. ACHV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $6.24 | $6.43 | $6.61 | +0.08% |
| Aug 3 | $6.18 | $6.43 | $6.70 | +0.17% |
| Aug 4 | $6.12 | $6.44 | $6.76 | +0.25% |
| Aug 5 | $6.08 | $6.44 | $6.82 | +0.33% |
| Aug 6 | $6.05 | $6.45 | $6.87 | +0.41% |
| Aug 7 | $6.01 | $6.45 | $6.92 | +0.50% |
| Aug 8 | $5.99 | $6.46 | $6.97 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.99 | $6.46 | $6.97 | +0.58% |
| Week 2 | $5.83 | $6.49 | $7.23 | +1.16% |
| Week 3 | $5.73 | $6.53 | $7.45 | +1.75% |
| Week 4 | $5.65 | $6.57 | $7.64 | +2.34% |
| Week 5 | $5.58 | $6.61 | $7.83 | +2.93% |
| Week 6 | $5.52 | $6.65 | $8.00 | +3.52% |
| Week 7 | $5.47 | $6.68 | $8.17 | +4.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Achieve Life Sciences, Inc. (ACHV) is a healthcare company described as a late-stage pharmaceutical company. It develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
The company has license and supply agreements with Sopharma AD and University of Bristol. It is headquartered in Bothell, Washington.
Achieve Life Sciences trades under the ACHV ticker and is currently priced at $6.30. The stock has a market capitalization of $646.75M and is ranked 2661 by market cap. The near-term forecast shows the 2026 average price at $6.30, with a low of $2.65 and a high of $9.11, and an overall neutral sentiment for that year.
From 2027 onward, the forecast envisions a bullish trajectory with higher average prices, culminating in substantial upside by 2050, including an average of $164.62 in 2050 and a very high upside relative to today.
A major floor 58.7% below — a decisive break under it would weaken the trend.
The nearest floor, 24.5% below — buyers have tended to step in here.
Price is pressing into resistance (1.7% away) — a breakout level to watch.
A major ceiling 18.6% above — clearing it would confirm fresh momentum.
Key ACHV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACHV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.25 | Buy | $6.29 | Buy |
| MA 10 | $6.26 | Buy | $6.26 | Buy |
| MA 20 | $6.26 | Buy | $6.18 | Buy |
| MA 50 | $5.73 | Buy | $5.78 | Buy |
| MA 100 | $4.92 | Buy | $5.30 | Buy |
| MA 200 | $4.77 | Buy | $4.78 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.67 | Neutral |
| Stoch RSI (14) | 79.66 | Neutral |
| CCI (20) | 88.52 | Neutral |
| Williams %R (14) | -14.81 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 1.42 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 85.19 | Sell |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 0.23 | Buy |
| Ultimate (7,14,28) | 60.37 | Neutral |
| Momentum (10) | 0.15 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 6.29 | Buy |
| ADX (14) | 14.41 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day price range is $5.19 to $7.64, indicating a price ceiling near the current level with room to move higher and lower. The current price of $6.30 sits above the 50-day simple moving average of $5.69 and above the 200-day simple moving average of $4.76, suggesting a short-term bullish tilt. RSI(14) is 60, which indicates neutral to bullish momentum, and the stock shows support at $4.85 with resistance at $6.53 in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.65 | $6.42 | $9.25 | 0% | Neutral | |
| $6.76 | $8.51 | $11.35 | +33% | Bullish | |
| $9.45 | $12.26 | $17.00 | +91% | Bullish | |
| $12.28 | $16.33 | $23.34 | +154% | Bullish | |
| $13.31 | $18.09 | $26.53 | +182% | Bullish | |
| $15.44 | $21.40 | $32.10 | +233% | Bullish | |
| $17.13 | $24.19 | $37.00 | +277% | Bullish | |
| $18.30 | $26.29 | $40.94 | +309% | Bullish | |
| $20.55 | $30.01 | $47.52 | +368% | Bullish | |
| $24.56 | $36.43 | $58.56 | +467% | Bullish | |
| $37.87 | $60.33 | $103.40 | +840% | Bullish | |
| $91.78 | $165.47 | $311.22 | +24.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.65 | $6.42 | $8.21 | +0.00% |
| September 2026 | $5.91 | $7.00 | $8.54 | +9.06% |
| October 2026 | $5.80 | $6.92 | $8.53 | -1.15% |
| November 2026 | $5.91 | $7.09 | $8.82 | +2.46% |
| December 2026 | $6.11 | $7.37 | $9.25 | +3.95% |
Click any year to see its month-by-month ACHV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ACHV could reach as high as $9.25, with a base case around $6.42 and support toward $2.65 — roughly 0% from $6.42. A consolidation phase looks the most probable path here.
Expect ACHV to range from $6.76 to $11.35 through 2027. The $8.51 average target implies a +33% move from current prices. That is up +33% on the projected 2026 average. Momentum favours further upside here.
The ACHV price prediction for 2028 points to an average of $12.26 (low $9.45, high $17.00) — a potential gain of +91% on today's $6.42. Buyers look set to stay in control over this stretch.
In 2029, ACHV is projected to trade between $12.28 and $23.34, averaging $16.33 — a potential gain of +154% from today's $6.42. That is up +33% on the projected 2028 average. Momentum favours further upside here.
Achieve Life Sciences, Inc.'s 2030 outlook centres on $18.09, within a $13.31 to $26.53 range. That is up +11% on the projected 2029 average. That marks a +182% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ACHV could reach as high as $32.10, with a base case around $21.40 and support toward $15.44 — roughly +233% from $6.42. Momentum favours further upside here.
Expect ACHV to range from $17.13 to $37.00 through 2032. The $24.19 average target implies a +277% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ACHV price prediction for 2033 points to an average of $26.29 (low $18.30, high $40.94) — a potential gain of +309% on today's $6.42. Momentum favours further upside here.
In 2034, ACHV is projected to trade between $20.55 and $47.52, averaging $30.01 — a potential gain of +368% from today's $6.42. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Achieve Life Sciences, Inc.'s 2035 outlook centres on $36.43, within a $24.56 to $58.56 range. That is up +21% on the projected 2034 average. That marks a +467% change versus current levels. Momentum favours further upside here.
By 2040, ACHV could reach as high as $103.40, with a base case around $60.33 and support toward $37.87 — roughly +840% from $6.42. Buyers look set to stay in control over this stretch.
Expect ACHV to range from $91.78 to $311.22 through 2050. The $165.47 average target implies a +24.8x move from current prices. That is up +174% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ACHV today (≈ 155.76324 ACHV) could be worth
$25,774.64
+$24,774.64 (+2477%) by 2050 · US Dollar
Based on the average projected ACHV price of $165.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACHVwould be worth at today's price.
$1,000 invested in ACHV on Jul 31, 2025 (≈ 383.141778 ACHV) would be worth
$2,459.77
+$1,459.77 (+146.0%) today · 2.46× · US Dollar
Based on a ACHV entry price of $2.61 vs. today's $6.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.1 | $1,052.46 | +5.2% |
| 1 month ago | $6.4 | $1,003.12 | +0.3% |
| 3 months ago | $4.38 | $1,465.75 | +46.6% |
| 6 months ago | $4.3 | $1,493.02 | +49.3% |
| 1 year ago | $2.61 | $2,459.77 | +146.0% |
| All time (5.0y) ago | $7.26 | $884.3 | -11.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACHV forecast.
Our base-case forecast reaches $13.00 around 2029.
Implied market cap at $13.00: $1.33B
The multi-year forecast illustrates a bullish trajectory, with rising averages across the horizon. In 2027 the average is $8.35, followed by $12.09 in 2028 and $16.15 in 2029, signaling steady upside beyond the current level. By 2030, the forecast shows an average of $17.86 with a return on investment of 183.4%, reinforcing a strong longer-term upside path.
Looking further out, 2040 carries an average of $59.84 with an upside of 849.9% and a 2050 average of $164.62, implying substantial, long-range appreciation. The forecast remains bullish through 2050, with a projected maximum of $312.35 in 2050. These figures are estimates and not guarantees, and actual results will depend on a range of factors including clinical, regulatory, and market dynamics.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $17.86, a minimum of $13.08, and a maximum of $26.32, with a forecasted ROI of 183.4% and a bullish sentiment.
Forecasts indicate a bullish path beyond 2026, with higher 2027–2050 averages (e.g., 2027 avg $8.35, 2030 avg $17.86, 2050 avg $164.62) and substantial upside implied by the max values. These are estimates, not guarantees, and actual results may vary.
Yes. The forecast shows a maximum of $103.33 in 2040 and a maximum of $312.35 in 2050, indicating that hitting or surpassing $100 is within the projected range according to the data.
Current price is $6.30 and market capitalization is $646.75M.
The 30-day range is $5.19 to $7.64.
Achieve Life Sciences, Inc. Community Discussion
0Share your Achieve Life Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.